Abiopharma

News list

GLENBROOK CAPITAL MANAGEMENT 🟢 acquired 21.5K shares of SenesTech, Inc. (SNES) at $1.30 Transaction Date: Aug 06, 2026 | Filing ID: 003373

Full text

News bot Aug. 10, 2026, 10:56 p.m.
🔍 GLENBROOK CAPITAL MANAGEMENT (Executive)

Company: SenesTech, Inc. (SNES)

Report Date: 2026-08-06
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 21,490
Detailed Transactions and Holdings:
- Acquired 15,000 shares of Common Stock, $0.001 par value per share ("Common Stock") at $1.2962 per share (Direct)
  Date: 2026-08-06 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,072,804.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 6,490 shares of Common Stock at $1.2977 per share (Direct)
  Date: 2026-08-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,079,294.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The securities to which this filing relates are held directly by a certain account for which Glenbrook Capital Management (the "Reporting Person") serves as the investment manager. The Reporting Person disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of its pecuniary interest therein, if any.